Zobrazeno 1 - 10
of 63
pro vyhledávání: '"Hanna Kwiendacz"'
Autor:
Katarzyna Nabrdalik, Mirela Hendel, Krzysztof Irlik, Hanna Kwiendacz, Igor Łoniewski, Tommaso Bucci, Uazman Alam, Gregory Y. H. Lip, Janusz Gumprecht, Karolina Skonieczna-Żydecka
Publikováno v:
BMC Endocrine Disorders, Vol 24, Iss 1, Pp 1-24 (2024)
Abstract Introduction Metformin is the most prescribed medication for type 2 diabetes mellitus (T2DM); there is a well-established link with the elevated incidence of gastrointestinal (GI) adverse events (AE) limiting its administration or intensific
Externí odkaz:
https://doaj.org/article/0c80e494fdae48e79295f021b6f450c2
Autor:
Oliwia Janota, Marta Mantovani, Hanna Kwiendacz, Krzysztof Irlik, Tommaso Bucci, Steven H. M. Lam, Bi Huang, Uazman Alam, Giuseppe Boriani, Mirela Hendel, Julia Piaśnik, Anna Olejarz, Aleksandra Włosowicz, Patrycja Pabis, Wiktoria Wójcik, Janusz Gumprecht, Gregory Y. H. Lip, Katarzyna Nabrdalik
Publikováno v:
Cardiovascular Diabetology, Vol 23, Iss 1, Pp 1-12 (2024)
Abstract Background There is a growing burden of non-obese people with diabetes mellitus (DM). However, their cardiovascular risk (CV), especially in the presence of cardiovascular-kidney-metabolic (CKM) comorbidities is poorly characterised. The aim
Externí odkaz:
https://doaj.org/article/786ad837b6d046938ce186d43790c87e
Autor:
Katarzyna Nabrdalik, Krzysztof Irlik, Yanda Meng, Hanna Kwiendacz, Julia Piaśnik, Mirela Hendel, Paweł Ignacy, Justyna Kulpa, Kamil Kegler, Mikołaj Herba, Sylwia Boczek, Effendy Bin Hashim, Zhuangzhi Gao, Janusz Gumprecht, Yalin Zheng, Gregory Y. H. Lip, Uazman Alam
Publikováno v:
Cardiovascular Diabetology, Vol 23, Iss 1, Pp 1-10 (2024)
Abstract Background Cardiac autonomic neuropathy (CAN) in diabetes mellitus (DM) is independently associated with cardiovascular (CV) events and CV death. Diagnosis of this complication of DM is time-consuming and not routinely performed in the clini
Externí odkaz:
https://doaj.org/article/caf7899cac6f43999cb6e01e9282ccaf
Autor:
Katarzyna Nabrdalik, Hanna Kwiendacz, Krzysztof Irlik, Mirela Hendel, Karolina Drożdż, Agata M. Wijata, Jakub Nalepa, Oliwia Janota, Wiktoria Wójcik, Janusz Gumprecht, Gregory Y. H. Lip
Publikováno v:
Cardiovascular Diabetology, Vol 22, Iss 1, Pp 1-14 (2023)
Abstract Background Diabetes mellitus (DM), heart failure (HF) and metabolic dysfunction associated steatotic liver disease (MASLD) are overlapping diseases of increasing prevalence. Because there are still high numbers of patients with HF who are un
Externí odkaz:
https://doaj.org/article/8aca06d1abed47ce9a09963c9e74139c
Autor:
Hanna Kwiendacz, Agata M. Wijata, Jakub Nalepa, Julia Piaśnik, Justyna Kulpa, Mikołaj Herba, Sylwia Boczek, Kamil Kegler, Mirela Hendel, Krzysztof Irlik, Janusz Gumprecht, Gregory Y. H. Lip, Katarzyna Nabrdalik
Publikováno v:
Cardiovascular Diabetology, Vol 22, Iss 1, Pp 1-12 (2023)
Abstract Aims As cardiovascular disease (CVD) is a leading cause of death for patients with diabetes mellitus (DM), we aimed to find important factors that predict cardiovascular (CV) risk using a machine learning (ML) approach. Methods and results W
Externí odkaz:
https://doaj.org/article/23a7bd4dde0647839b55db91dafcda96
Autor:
Katarzyna Nabrdalik, Karolina Drożdż, Hanna Kwiendacz, Karolina Skonieczna-Żydecka, Igor Łoniewski, Mariusz Kaczmarczyk, Agata M. Wijata, Jakub Nalepa, Frits Holleman, Max Nieuwdorp, Janusz Gumprecht
Publikováno v:
Biomedicine & Pharmacotherapy, Vol 168, Iss , Pp 115650- (2023)
Background: For decades, metformin has been the drug of first choice in the management of type 2 diabetes. However, approximately 2–13% of patients do not tolerate metformin due to gastrointestinal (GI) side effects. Since metformin influences the
Externí odkaz:
https://doaj.org/article/c811509036024b219e957cef323f54fe
Autor:
Katarzyna Nabrdalik, Andrzej Tomasik, Krzysztof Irlik, Mirela Hendel, Hanna Kwiendacz, Edyta Radzik, Katarzyna Pigoń, Tomasz Młyńczak, Janusz Gumprecht, Ewa Nowalany-Kozielska, Gregory Y. H. Lip
Publikováno v:
Scientific Reports, Vol 13, Iss 1, Pp 1-8 (2023)
Abstract Type 2 diabetes mellitus (T2DM) and diminished myocardial perfusion increase the risk of heart failure (HF) and/or all-cause mortality during 6-year follow up following primary percutaneous coronary intervention (pPCI) for ST elevation myoca
Externí odkaz:
https://doaj.org/article/87dd56fa8acd409d850ffbd6c593ab0b
Autor:
Karolina Drożdż, Katarzyna Nabrdalik, Hanna Kwiendacz, Mirela Hendel, Anna Olejarz, Andrzej Tomasik, Wojciech Bartman, Jakub Nalepa, Janusz Gumprecht, Gregory Y. H. Lip
Publikováno v:
Cardiovascular Diabetology, Vol 21, Iss 1, Pp 1-12 (2022)
Abstract Background Nonalcoholic fatty liver disease is associated with an increased cardiovascular disease (CVD) risk, although the exact mechanism(s) are less clear. Moreover, the relationship between newly redefined metabolic-associated fatty live
Externí odkaz:
https://doaj.org/article/cf35e9779eb14389bd392a98e1ec8e61
Autor:
Katarzyna Cyranka, Anna Juza, Hanna Kwiendacz, Katarzyna Nabrdalik, Janusz Gumprecht, Maciej Małecki, Tomasz Klupa, Bartłomiej Matejko
Publikováno v:
JMIR Formative Research, Vol 7, p e46513 (2023)
BackgroundThe transition period of patients with type 1 diabetes from pediatric to adult-oriented health care is associated with poorer glycemic control and less frequent clinic attendance. Fears and anxiety about the unknown, care approach differenc
Externí odkaz:
https://doaj.org/article/56ea4cb10e5c47e9a70ce2ab87b2f725
Autor:
Katarzyna Nabrdalik, Karolina Skonieczna-Żydecka, Krzysztof Irlik, Mirela Hendel, Hanna Kwiendacz, Igor Łoniewski, Kornelia Januszkiewicz, Janusz Gumprecht, Gregory Y. H. Lip
Publikováno v:
Frontiers in Endocrinology, Vol 13 (2022)
IntroductionMetformin is the first choice drug in the treatment of type 2 diabetes mellitus but its administration may be linked to gastrointestinal adverse events limiting its use.ObjectivesThe objective of this systematic review and meta-analysis w
Externí odkaz:
https://doaj.org/article/d406ec8fb0954df8b28af24c599d78bb